Stephan Siegmann

Title: Innovations of Stephan Siegmann in Biocompatible Surface Layers

Introduction

Stephan Siegmann is a notable inventor based in Pfäffikon, Switzerland. He has made significant contributions to the field of biocompatible materials, particularly in the development of surface layers for implants. His innovative work focuses on enhancing the compatibility and functionality of medical implants through advanced material science.

Latest Patents

One of Siegmann's key patents is titled "Open-pore biocompatible surface layer for an implant, methods of production and use." This invention pertains to open-pore biocompatible surface layers designed for implants. These layers are strategically arranged over the virgin surfaces of the implants, with pores that are interconnected to form coherent pore networks. The surface layers possess a specific internal surface area of ≥0.06 μm/μm, preferably ≥0.035 μm/μm, and especially ≥0.025 μm/μm, as measured by image analysis in a metallographic microsection at 100× magnification. The patent also covers methods for producing these surface layers, the implants coated with them, and their potential applications in medical technology.

Career Highlights

Stephan Siegmann is currently associated with Smith & Nephew Orthopaedics AG, where he continues to innovate in the field of orthopaedic implants. His work has been instrumental in advancing the design and functionality of medical devices, ensuring better patient outcomes through improved implant technology.

Collaborations

Throughout his career, Siegmann has collaborated with esteemed colleagues, including Reto Lerf and Hans F Schmotzer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their innovations.

Conclusion

Stephan Siegmann's contributions to the field of biocompatible surface layers for implants exemplify the importance of innovation in medical technology. His patented work not only advances the science of implant materials but also holds the potential to significantly improve patient care.